Incidence of Atrial Fibrillation in Large Vessel Occlusion and Large Embolic Stroke of Undetermined Source.
atrial fibrillation
embolic stroke
esus
large vessel occlusion
stroke
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
accepted:
12
01
2023
entrez:
16
2
2023
pubmed:
17
2
2023
medline:
17
2
2023
Statut:
epublish
Résumé
Large vessel occlusion (LVO) stroke is a common presentation of acute ischemic stroke and is often unknown or cryptogenic in etiology. There is a strong association between atrial fibrillation (AF) and cryptogenic LVO stroke, making it a unique stroke subgroup. Therefore, we propose that any LVO stroke meeting the criteria for an embolic stroke of an undetermined source (ESUS) be classified as large ESUS (LESUS). The purpose of this retrospective cohort study was to report the etiology of anterior LVO strokes that underwent endovascular thrombectomy. This was a single-center retrospective cohort study characterizing the etiology of acute anterior circulation LVO strokes that received emergent endovascular thrombectomy from 2011 to 2018. Patients with LESUS designation at hospital discharge were changed to cardioembolic etiology if AF was discovered during the two-year follow-up period. Results: Overall, 155 (45%) of 307 patients in the study were found to have AF. New onset AF was discovered in 12 (23%) of 53 LESUS patients after hospitalization. Furthermore, eight (35%) of 23 LESUS patients who received extended cardiac monitoring were found to have AF. Nearly half the patients with LVO stroke who received endovascular thrombectomy were found to have AF. With the use of extended cardiac monitoring devices after hospitalization, AF is frequently discovered in patients with LESUS and may change the secondary stroke prevention strategy.
Identifiants
pubmed: 36793841
doi: 10.7759/cureus.33700
pmc: PMC9925036
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e33700Informations de copyright
Copyright © 2023, Seachrist et al.
Déclaration de conflit d'intérêts
The authors have declared financial relationships, which are detailed in the next section.
Références
N Engl J Med. 2019 May 16;380(20):1906-1917
pubmed: 31091372
Int J Stroke. 2019 Feb;14(2):207-214
pubmed: 30196789
Front Neurol. 2020 Nov 12;11:580572
pubmed: 33281716
JAMA Neurol. 2019 Apr 1;76(4):405-411
pubmed: 30667465
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Stroke Cerebrovasc Dis. 2018 Apr;27(4):886-891
pubmed: 29196201
JAMA. 2021 Jun 1;325(21):2169-2177
pubmed: 34061145
J Neuroimaging. 2019 Jul;29(4):463-466
pubmed: 30900276
J Am Coll Cardiol. 2019 Jul 9;74(1):104-132
pubmed: 30703431
Neurologia. 2014 Jun;29(5):261-6
pubmed: 24075584
Stroke. 2020 Mar;51(3):1014-1016
pubmed: 31847752
J Neurointerv Surg. 2020 Mar;12(3):260-265
pubmed: 31444289
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Drugs. 2018 Jun;78(8):823-831
pubmed: 29737498
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1673-1682
pubmed: 29525076
JAMA Cardiol. 2017 Oct 1;2(10):1120-1127
pubmed: 28842973
Stroke. 1996 Oct;27(10):1760-4
pubmed: 8841325
Stroke. 2014 Jul;45(7):2160-236
pubmed: 24788967
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Stroke. 2019 Jul;50(7):1907-1910
pubmed: 31138084
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
JAMA. 2021 Jan 5;325(1):81-82
pubmed: 33399834
J Neurointerv Surg. 2019 Mar;11(3):241-245
pubmed: 30415226
J Am Heart Assoc. 2018 Dec 18;7(24):e010867
pubmed: 30561262
Eur Heart J Suppl. 2020 Dec 06;22(Suppl M):M51-M59
pubmed: 33664640
Eur J Neurol. 2020 Aug;27(8):1618-1624
pubmed: 32347993
Circulation. 2018 Jul 17;138(3):229-231
pubmed: 30012700
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
N Engl J Med. 2018 Jun 07;378(23):2191-2201
pubmed: 29766772